Budget Impact of the LungFlag™ Predictive Risk Model for Lung Cancer Screening
Using LungFlag to identify candidates for lung cancer screening was estimated to save US$2.8 million over 5 years from a US commercial health plan perspective, largely attributable to reduced costs of treating advanced NSCLC.
Authors
- Eran Choman
- Milan Obradović (ORCID: https://orcid.org/0000-0002-4769-2652)
- Sarika Ogale
- N. Olghi
- Michael Gould (ORCID: https://orcid.org/0000-0003-2784-9576)
- Carolina Heuser (ORCID: https://orcid.org/0009-0004-1454-4110)
Institutions
- Roche (Switzerland) (CH)
- Kaiser Permanente (US)
Publication Details
- Journal
- PharmacoEconomics - Open
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1007/s41669-025-00627-6
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00